Home 
Blogs Chief Editor Rob Wright
Blogs Chief Editor Rob Wright
In July I had the opportunity to attend the Bio-Process Systems Alliance (BPSA) International Single-Use Summit in Washington, D.C. Formed in 2005, BPSA is an industry-led corporate-member trade association dedicated to encouraging and accelerating the adoption of single-use manufacturing technologies used in the production of biopharmaceuticals and vaccines. In my opinion, BPSA has been successful…
Thursday, 26 July 2012 19:06
How To Implement A Pharma Manufacturing Serialization Program
Written by Rob Wright
If you were charged with implementing a serialization program at a pharmaceutical manufacturing facility, what would be your bulleted approach to implementing, with timelines and specific recommendations for completion? This was a question posed to David Harty, a 20+ years IT solutions and software expert. Formerly with such well-known companies as VeriSign and Siemens, he…
For pharmaceutical manufacturers holding out hope that California’s ePedigree law will be postponed, Virginia Herold, executive officer of the California State Board of Pharmacy, has stated that the 2015-to-2017 deadlines are firm and that there will be no further extensions. The California State Board of Pharmacy initially stepped into this area of regulation out of…
Wednesday, 18 July 2012 14:50
What No One Is Talking About Regarding Traceability
Written by Rob Wright
In February, Genentech, the maker of the best-selling cancer drug, Avastin, issued a warning to doctors and patients, noting that the counterfeit vials of the distributed product did not contain the key ingredient used to treat cancers of the colon, lung, kidney, and brain. Charlotte Arnold, a spokeswoman for Genentech, said the counterfeit drug had…
Friday, 13 July 2012 14:41
FDA Announcements Don’t Impact Stock Price – Thanks To Insider Trading
Written by Rob Wright
Matthew Herper wrote an article about a tiny biotech preparing for its initial public offering by licensing a promising anti-cancer drug from Merck. According to Herper, the start-up is attempting to repeat the success its top executives had turning Big Pharma’s castoffs into hits at MGI Pharma — bought by Eisai for $3.9 billion in…
The department of science and technology in South Africa put together a 10-year plan to innovate toward a knowledge based-economy (2008 – 2018). The plan notes the tremendous gap which exists between South Africa and those countries identified as knowledge-based economies. Four driving elements to make the move toward being more knowledge-based are human capital…
I just returned from the 2012 Bio International show, held in Boston (June 17 – 21). On the cover of my dog-eared Bio pocket guide, it has three words — connect, partner, and innovate. As I look over my 20 + pages of notes and stack of business cards, I asked myself these questions, “Does…
At this year’s Interphex conference, I had the opportunity to host a roundtable dinner event. The group was diverse, including readers, advertisers, and a member of our editorial advisory board, John LaMattina. A 30+ year pharma veteran, LaMattina is the former president of Pfizer’s R&D program and has his own blog with Forbes (http://blogs.forbes.com/johnlamattina/), a…
Wednesday, 13 June 2012 03:11
A Simple Way To Improve Diversity In Clinical Trials
Written by Rob Wright
As I prepared to moderate a panel discussion on provider perspectives for improving diversity in clinical trials, I was reminded of the Occam’s Razor principle — “The simplest explanation for some phenomenon is more likely to be accurate than more complicated explanations.” I was also reminded of another famous saying — “Physician, heal thyself.”
Vijay Govindarajan, recently sent me a copy of his book, Reverse Innovation. I have to admit, I am a raving fan. Probably because the last two articles I wrote for Life Science Leader’s June 2012 issue focused on innovation. I began reading Reverse Innovation prior to attending Interphex 2012. During discussions with people like Richard…
Editorial Board Blogs
-
Innovative Companies and Investment Trends in Clean Tech at World Congress
Innovative Companies and Investment Trends in Clean Tech at World Congress
A recent Reuters article says the U.S. biotech sector is picking up steam in 2013 as deals are happening and attractive returns are generated. According to Reuters, “biotech IPOs have turned in a strong performance, delivering an average return of[…]
Source: BIOtechNow
-
Pharma Continues To Seek External R&D Funding, This Time From The Government
Pharma Continues To Seek External R&D Funding, This Time From The Government
Pharma companies have traditionally funded their internal R&D efforts totally on their own by investing 15% or more of their top line revenues to pay for these endeavors. In addition, in order to tap into R&D going on outside[…]
Source: Drug Truths
-
Roundtable Discussion Highlights Innovation, Commercial Reality for Renewable Chemical Products
Roundtable Discussion Highlights Innovation, Commercial Reality for Renewable Chemical Products
Last week BIO brought together representatives from five renewable chemical companies that will be speaking at BIO’s World Congress on Industrial Biotechnology next month in Montreal for a roundtable discussion highlighting developments in the renewable chemical space. Bioformix, Itaconix, Newlight[…]
Source: BIOtechNow
-
Pharma’s R&D Deals With Foundations May Negatively Impact Image
Pharma’s R&D Deals With Foundations May Negatively Impact Image
On the surface, it sounds pretty reasonable. Foundations like the Michael J. Fox Foundation and the Cystic Fibrosis Foundation (CFF), in their attempts to accelerate the discovery and development of new drugs, have turned to pharmaceutical companies for help. One[…]
Source: Drug Truths
-
Leadership Lesson: The Difference Between Google and Apple
Leadership Lesson: The Difference Between Google and Apple
By Mike Myatt, Chief Executive Officer, N2growth
Google and Apple are both highly esteemed brands. Both companies share many common traits which have contributed to their success, but there is one very big difference between the two – Google plays[…]
Source: N2Growth Blog
-
Careering around in Cheltenham!
Careering around in Cheltenham!
Careering around in Cheltenham! By Katrina Brockbank Last month I attended the Cheltenham Festivals “Careering Around” careers fair. Run by STEMNET (Science, Technology, Engineering and Mathematics network) the careers fair aimed to introduce young people to the professional opportunities that[…]
Source: Freeman Technology - Free Flow
-
How To Predict The Future
How To Predict The Future
By Mike Myatt, Chief Executive Officer, N2growth
Life is just plain easier when you can see what’s ahead of you. Some leaders clearly have poor vision – their most polished skill seems to be running into brick walls. Other leaders[…]
Source: N2Growth Blog
-
The missing link?
The missing link?
The missing link? By Tim Freeman I recently attended the Arden House Conference (48th AAPS Annual Arden House Conference) which this year was focusing on advances in pharmaceutical material characterisation and their importance in the effective application of QbD. There[…]
Source: Freeman Technology - Free Flow
By A Web Design
